| Rs | CCC(95%CI) | ROCAUC(95%CI) | Sensitivity | Specificity | Youden index | Kappa |
---|---|---|---|---|---|---|---|
All Participants(N = 612) | |||||||
 CKD-EPI | 0.872a | 0.843 (0.820,0.863) | 0.925 (0.902,0.945)* | 87.7 | 83.5 | 0.712 | 0.438** |
 LMR | 0.873a | 0.855 (0.833,0.874) | 0.926 (0.903,0.946)* | 86.6 | 84.8 | 0.714 | 0.473** |
 BIS1 | 0.871a | 0.863 (0.841,0.882) | 0.926 (0.902,0.945)* | 82.4 | 88.6 | 0.710 | 0.485** |
 FAS | 0.873a | 0.864 (0.843,0.883) | 0.927 (0.903,0.947)* | 87.7 | 84.2 | 0.718 | 0.482** |
 EKFC | 0.874a | 0.849 (0.827,0.869) | 0.927 (0.912,0.952)* | 85.2 | 86.7 | 0.720 | 0.477** |
Participants Aged 65–79 Years(N = 444) | |||||||
 CKD-EPI | 0.898a | 0.858 (0.834,0.879) | 0.943 (0.917,0.962)* | 89.3 | 85.6 | 0.750 | 0.491** |
 LMR | 0.896a | 0.870 (0.847,0.890) | 0.943 (0.917,0.962)* | 87.2 | 88.8 | 0.760 | 0.478** |
 BIS1 | 0.896a | 0.880 (0.857,0.899) | 0.943 (0.917,0.962)* | 86.8 | 88.8 | 0.756 | 0.489** |
 FAS | 0.898a | 0.880 (0.858,0.899) | 0.944 (0.918,0.963)* | 88.4 | 88.0 | 0.764 | 0.488** |
 EKFC | 0.898a | 0.863 (0.839,0.884) | 0.943 (0.918,0.963)* | 88.4 | 88.0 | 0.764 | 0.487** |
Participants Aged ≥80 Years(N = 168) | |||||||
 CKD-EPI | 0.760a | 0.773 (0.707,0.825) | 0.858 (0.796,0.907)* | 84.4 | 75.8 | 0.602 | 0.441** |
 LMR | 0.762a | 0.784 (0.720,0.836) | 0.858 (0.796,0.907)* | 84.4 | 75.8 | 0.602 | 0.438** |
 BIS1 | 0.762a | 0.788 (0.724,0.838) | 0.859 (0.797,0.908)* | 84.4 | 75.8 | 0.602 | 0.453** |
 FAS | 0.762a | 0.791 (0.727,0.842) | 0.860 (0.798,0.909)* | 84.4 | 75.8 | 0.602 | 0.449** |
 EKFC | 0.761a | 0.784 (0.719,0.835) | 0.858 (0.796,0.907)* | 83.7 | 75.8 | 0.595 | 0.429** |
Male(N = 386) | |||||||
 CKD-EPI | 0.862a | 0.833 (0.801,0.860) | 0.911 (0.878,0.937)* | 85.5 | 84.5 | 0.700 | 0.490** |
 LMR | 0.886a | 0.840 (0.808,0.867) | 0.913 (0.881,0.939)* | 85.2 | 85.4 | 0.706 | 0.431** |
 BIS1 | 0.865a | 0.838 (0.807,0.864) | 0.914 (0.882,0.940)* | 83.0 | 86.4 | 0.695 | 0.469** |
 FAS | 0.865a | 0.841 (0.809,0.867) | 0.914 (0.881,0.940)* | 87.3 | 82.5 | 0.698 | 0.464** |
 EKFC | 0.865a | 0.838 (0.806,0.865) | 0.913 (0.880,0.939)* | 84.8 | 85.4 | 0.702 | 0.442** |
Female(N = 226) | |||||||
 CKD-EPI | 0.891a | 0.852 (0.820,0.879) | 0.951 (0.914,0.975)* | 93.0 | 85. 5 | 0.784 | 0.467** |
 LMR | 0.892a | 0.872 (0.841,0.898) | 0.953 (0.916,0.976)* | 91.8 | 87.3 | 0.791 | 0.537** |
 BIS1 | 0.889a | 0.894 (0.864,0.917) | 0.950 (0.913,0.975)* | 91.8 | 87.3 | 0.791 | 0.507** |
 FAS | 0.890a | 0.885 (0.855,0.909) | 0.950 (0.913,0.975)* | 91.8 | 87.3 | 0.791 | 0.508** |
 EKFC | 0.890a | 0.862 (0.829,0.888) | 0.951 (0.914,0.975)* | 92.4 | 87.3 | 0.797 | 0.528** |
Diabetic (N = 293) | |||||||
 CKD-EPI | 0.869a | 0.851 (0.819,0.878) | 0.934 (0.900,0.960)* | 84.7 | 90.8 | 0.754 | 0.484** |
 LMR | 0.869a | 0.858 (0.825,0.885) | 0.934 (0.899,0.959)* | 87.3 | 86.2 | 0.734 | 0.462** |
 BIS1 | 0.869a | 0.866 (0.835,0.891) | 0.934 (0.900,0.960)* | 84.7 | 90.8 | 0.754 | 0.466** |
 FAS | 0.872a | 0.872 (0.841,0.897) | 0.935 (0.900,0.960)* | 83.3 | 90.8 | 0.741 | 0.478** |
 EKFC | 0.871a | 0.858 (0.825,0.884) | 0.935 (0.901,0.961)* | 87.7 | 86.2 | 0.739 | 0.477** |
Non-diabetic(N = 319) | |||||||
 CKD-EPI | 0.871a | 0.834 (0.801,0.862) | 0.919 (0.884,0.947)* | 85.8 | 86.0 | 0.719 | 0.480** |
 LMR | 0.872a | 0.850 (0.818,0.877) | 0.920 (0.885,0.947)* | 87.6 | 83.9 | 0.715 | 0.481** |
 BIS1 | 0.867a | 0.859 (0.828,0.885) | 0.918 (0.882,0.946)* | 88.1 | 82.8 | 0.709 | 0.500** |
 FAS | 0.870a | 0.856 (0.824,0.883) | 0.920 (0.884,0.947)* | 87.2 | 86.0 | 0.732 | 0.484** |
 EKFC | 0.872a | 0.841 (0.808,0.869) | 0.919 (0.884,0.947)* | 88.9 | 83.9 | 0.728 | 0.474** |